Chia-Che Tsai, PhD
Deputy General Manager
Professional Information
Biography
Key leader at STEMCELL BioTech and lecturer at National Yang Ming Chiao Tung University, bridging academic research and commercial biotechnology applications.
Specialization
Clinical applications of cell-based therapeutics for acute respiratory failure
Education
Ph.D. in Biochemical Science, National Taiwan University (2004-2009); M.S. in Cell and Molecular Biology, Taipei Medical University (2002-2004); B.S. in Applied Chemistry, National Chiao Tung University (1998-2002)
Research & Publications
Dr. Tsai is a distinguished stem cell biologist with extensive research in: Isolation and characterization of neurogenic mesenchymal stem cells Development of screening platforms for immunoregulatory compounds Biodistribution and pharmacokinetics of therapeutic nanomedicines Immunomodulatory effects of natural compounds Development of stem cell therapies for osteoarthritis and chronic kidney disease 🫁 Clinical applications of cell-based therapeutics for acute respiratory failure His noteworthy publication "Development of an allogeneic stem cell product 'ELIXCYTE' for the treatment of osteoarthritis and chronic kidney disease" (Cytotherapy, 2020) represents a significant advancement in therapeutic applications of stem cells.